Sector
HealthcareOpen
₹864.75Prev. Close
₹862.8Turnover(Lac.)
₹302.4Day's High
₹879.9Day's Low
₹852.352 Week's High
₹931.3552 Week's Low
₹506.8Book Value
₹95.33Face Value
₹10Mkt Cap (₹ Cr.)
4,541.49P/E
57.47EPS
15.02Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 87.14 | 71.85 | 52.9 | 52.87 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 426.67 | 449.19 | 467.8 | 392.59 |
Net Worth | 513.81 | 521.04 | 520.7 | 445.46 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 561.53 | 474.27 | 400 | 331.79 |
yoy growth (%) | 18.39 | 18.56 | 20.55 | 11.51 |
Raw materials | -165.23 | -160.55 | -112.34 | -90.84 |
As % of sales | 29.42 | 33.85 | 28.08 | 27.37 |
Employee costs | -58.82 | -56.79 | -45.75 | -32.48 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 207.38 | 161.28 | 156.33 | 150.15 |
Depreciation | -28.47 | -21.08 | -19.54 | -12.08 |
Tax paid | -55.33 | -41.51 | -32.68 | -51.92 |
Working capital | 67.33 | 22.23 | -22.08 | -14.1 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 18.39 | 18.56 | 20.55 | 11.51 |
Op profit growth | 35.19 | 2.41 | 19.92 | 21.17 |
EBIT growth | 29.52 | 2.72 | 4.7 | 31.56 |
Net profit growth | 26.95 | 50.99 | -17.4 | 105.78 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 571.88 | 526.67 | 588.86 | 494.62 | 433.2 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 571.88 | 526.67 | 588.86 | 494.62 | 433.2 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 9.76 | 9.6 | 29.25 | 12.43 | 8.24 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,906.8 | 95.13 | 99,697.41 | 251.7 | 0.23 | 1,936.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 898.55 | 120.41 | 86,132.08 | 154.14 | 0.17 | 621.39 | 79.02 |
Fortis Healthcare Ltd FORTIS | 546.8 | 321.03 | 42,413.55 | 26.83 | 0.18 | 333.4 | 120.36 |
Syngene International Ltd SYNGENE | 899.65 | 81.15 | 36,520.17 | 73.9 | 0.14 | 726.5 | 104.14 |
Global Health Ltd MEDANTA | 1,110.95 | 82.82 | 30,713.76 | 96.28 | 0 | 611.45 | 106.08 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
GOPAL SHIVRAM HEGDE
Independent Director
Neetin Shivajirao Desai
Independent Director
VISHWAS MADHAV KULKARNI
Company Sec. & Compli. Officer
RAMJEE DORAI
Independent Director
Indumati Gopinathan
Non-Exec & Non-Independent Dir
Dhaval Shah
Non-Exec & Non-Independent Dir
Dharmil Sheth
Chairman & MD & CEO
Rahul Guha
Non-Exec & Non-Independent Dir
Hardik Dedhia
Independent Director
Prapti Ishwar Gilada
Independent Director
Harshil Jiten Vora
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Thyrocare Technologies Ltd
Summary
Thyrocare Technologies Limited was incorporated in the year January 28, 2000. The Company is one of the leading pan-India diagnostic chains that conduct an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases. As of 31 March 2022, the Company offered 636 distinct tests and 90 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases. Their 34 profiles are administered under its reputed Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs). The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.Nueclear Healthcare Limited (NHL), the wholly owned subsidiary of Thyrocare Technologies, is engaged in PET-CT Scan imaging diagnostic business. NHL currently has 10 active operating PET-CT scanners in 8 imaging centers: two in Navi Mumbai, two in New Delhi, one each in Hyderabad, Central Mumbai, Western Mumbai, Baroda, Nashik and Bangalore. NHL also owns
Read More
The Thyrocare Technologies Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹857.65 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Thyrocare Technologies Ltd is ₹4541.49 Cr. as of 06 Sep ‘24
The PE and PB ratios of Thyrocare Technologies Ltd is 57.47 and 9.53 as of 06 Sep ‘24
The 52-week high/low is the highest and lowest price at which a Thyrocare Technologies Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Thyrocare Technologies Ltd is ₹506.8 and ₹931.35 as of 06 Sep ‘24
Thyrocare Technologies Ltd's CAGR for 5 Years at 13.23%, 3 Years at -11.60%, 1 Year at 58.84%, 6 Month at 27.56%, 3 Month at 43.47% and 1 Month at 11.21%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice